deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01582789

Comparative Study of Two Marketed Spherical Soft Contact Lenses

Clinical Evaluation of CooperVision's Avaira Spherical Daily Wear Soft Contact Lens Versus Vistakon's Oasys Spherical Daily Wear Soft Contact Lens

Sponsor: CooperVision, Inc.

Updated 9 times since 2017 Last updated: Oct 5, 2020 Started: Apr 9, 2012 Primary completion: May 31, 2012 Completion: Jul 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Refractive Error, this trial is completed. The trial is conducted by CooperVision, Inc. and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotCompleted~Jan 2025 – ~May 2025 · 4 months · monthly snapshotCompleted~May 2025 – present · 14 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. May 2025 — Present [monthly]

    Completed NA

  2. Jan 2025 — May 2025 [monthly]

    Completed NA

  3. Sep 2024 — Jan 2025 [monthly]

    Completed NA

  4. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  5. Jan 2021 — Jul 2024 [monthly]

    Completed NA

Show 4 earlier versions
  1. Nov 2020 — Jan 2021 [monthly]

    Completed NA

    Phase: PHASE4NA

  2. Jun 2018 — Nov 2020 [monthly]

    Completed PHASE4

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CooperVision, Inc.
Data source: CooperVision International Limited (CVIL)

For direct contact, visit the study record on ClinicalTrials.gov .